- Home
- ADVB vs SNES Comparison
ADVB vs SNES Comparison
Compare ADVB & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- SNES
- Stock Information
- Founded
- ADVB 2014
- SNES 2004
- Country
- ADVB United States
- SNES United States
- Employees
- ADVB N/A
- SNES N/A
- Industry
- ADVB Medical Specialities
- SNES Agricultural Chemicals
- Sector
- ADVB Health Care
- SNES Industrials
- Exchange
- ADVB Nasdaq
- SNES Nasdaq
- Market Cap
- ADVB 20.8M
- SNES 21.0M
- IPO Year
- ADVB 2025
- SNES 2016
- Fundamental
- Price
- ADVB $0.44
- SNES $4.67
- Analyst Decision
- ADVB
- SNES Strong Buy
- Analyst Count
- ADVB 0
- SNES 1
- Target Price
- ADVB N/A
- SNES $10.00
- AVG Volume (30 Days)
- ADVB 2.3M
- SNES 195.8K
- Earning Date
- ADVB 08-26-2025
- SNES 08-07-2025
- Dividend Yield
- ADVB N/A
- SNES N/A
- EPS Growth
- ADVB N/A
- SNES N/A
- EPS
- ADVB N/A
- SNES N/A
- Revenue
- ADVB N/A
- SNES $2,093,000.00
- Revenue This Year
- ADVB N/A
- SNES $130.53
- Revenue Next Year
- ADVB N/A
- SNES $80.00
- P/E Ratio
- ADVB N/A
- SNES N/A
- Revenue Growth
- ADVB N/A
- SNES 36.89
- 52 Week Low
- ADVB $0.34
- SNES $1.30
- 52 Week High
- ADVB $4.10
- SNES $6.24
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- SNES 46.89
- Support Level
- ADVB N/A
- SNES $4.47
- Resistance Level
- ADVB N/A
- SNES $6.24
- Average True Range (ATR)
- ADVB 0.00
- SNES 0.41
- MACD
- ADVB 0.00
- SNES -0.13
- Stochastic Oscillator
- ADVB 0.00
- SNES 19.03
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.